Benitec Biopharma annual depreciation and amortization
2019
2020
2021
2022
2023
2024
2025
Benitec Biopharma Depreciation & Amortization Growth & History (BNTC)
Benitec Biopharma's depreciation and amortization was $66,000 for fiscal 2025.
View full Benitec Biopharma company overviewBenitec Biopharma annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | $66,000 | −$21,000 | −24.14% |
| 2024 | 2024-06-30 | $87,000 | −$49,000 | −36.03% |
| 2023 | 2023-06-30 | $136,000 | −$31,000 | −18.56% |
| 2022 | 2022-06-30 | $167,000 | −$64,000 | −27.71% |
| 2021 | 2021-06-30 | $231,000 | $41,000 | +21.58% |
| 2020 | 2020-06-30 | $190,000 | $32,000 | +20.25% |
| 2019 | 2019-06-30 | $158,000 | — | — |
Benitec Biopharma quarterly depreciation and amortization
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-03-31 | $14,000 | $1,000 | +7.69% |
| Q2 2026 | 2025-12-31 | $14,000 | $0 | 0.00% |
| Q1 2026 | 2025-09-30 | $13,000 | −$12,000 | −48.00% |
| Q4 2025 | 2025-06-30 | $118,000 | — | — |
| Q3 2025 | 2025-03-31 | $13,000 | −$12,000 | −48.00% |
| Q2 2025 | 2024-12-31 | $14,000 | −$3,000 | −17.65% |
| Q1 2025 | 2024-09-30 | $25,000 | $6,000 | +31.58% |
| Q3 2024 | 2024-03-31 | $25,000 | −$7,000 | −21.88% |
| Q2 2024 | 2023-12-31 | $17,000 | −$24,000 | −58.54% |
| Q1 2024 | 2023-09-30 | $19,000 | −$23,000 | −54.76% |
| Q3 2023 | 2023-03-31 | $32,000 | −$22,000 | −40.74% |
| Q2 2023 | 2022-12-31 | $41,000 | −$14,000 | −25.45% |
| Q1 2023 | 2022-09-30 | $42,000 | −$10,000 | −19.23% |
| Q3 2022 | 2022-03-31 | $54,000 | −$13,000 | −19.40% |
| Q2 2022 | 2021-12-31 | $55,000 | −$12,000 | −17.91% |
| Q1 2022 | 2021-09-30 | $52,000 | $7,000 | +15.56% |
| Q3 2021 | 2021-03-31 | $67,000 | $19,000 | +39.58% |
| Q2 2021 | 2020-12-31 | $67,000 | $16,000 | +31.37% |
| Q1 2021 | 2020-09-30 | $45,000 | −$6,000 | −11.76% |
| Q3 2020 | 2020-03-31 | $48,000 | — | — |
| Q2 2020 | 2019-12-31 | $51,000 | — | — |
| Q1 2020 | 2019-09-30 | $51,000 | — | — |
Benitec Biopharma depreciation and amortization trends
Over the last five fiscal years, Benitec Biopharma's depreciation and amortization decreased from $190,000 to $66,000, a change of −$124,000. The latest reported quarter, Q3 2026, shows $14,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Benitec Biopharma source filings ↗